Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
PhD from MIT and researched at Broad Institute